Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted therapies study in rheumatoid arthritis
NL-OMON61322Phase 1Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2026
- Countries
- 1
01
Overview
Phase 1 trial, sponsored by AbbVie Inc. Started Oct 2026; status: completed.
Beyond the preview
Go deeper on NL-OMON61322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61322.